The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection. (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13059-023-02881-5
PubMed Identifier: 36915185
Publication URI: http://europepmc.org/abstract/MED/36915185
Type: Journal Article/Review
Volume: 24
Parent Publication: Genome biology
Issue: 1
ISSN: 1474-7596